ECJ: potential competition exists between originators and generics
Credit: Shutterstock/Willy Barton
The European Court of Justice has held that competition can exist between a pharmaceutical patent-holder and generic drugmakers that are in a patent dispute.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now